Kyntra Bio KYNB
NASDAQ KYNB
$5.21 -0.14 (-2.70%)
As of: Oct 21, 2026 · 11:26 AM EDT

Kyntra Bio (KYNB) Acquisitions (2020)

Updated

Kyntra Bio (KYNB) reported Acquisitions of $656,000 for FY2023.

Analysis

Kyntra Bio (KYNB) Acquisitions (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -17.24 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Kyntra Bio 21.09 Mn -386.85 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 726,000.00
API Access

Kyntra Bio Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=KYNB&period=max&api_key=YOUR_API_KEY